IGC Pharma, Inc. (IGC) Executive Compensation
IGC Pharma, Inc. (IGC) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IGC
CIK: 1326205
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: MD
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MANOHAR CHOWDHRY & ASSOCIATES
Auditor SinceSince 3/31/2018 12:00:00 AM
Lead Engagement PartnerSuryanandh KSY
Audit LocationChennai, India
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-29 | 2026-09-25 | 4 Filing | 0001185185-26-004409 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | 4 Filing | 0001185185-26-004408 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001185185-26-003544 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-13 | FORM 8-K | 0001185185-26-002922 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-06-30 | FORM 8-K | 0001185185-26-002808 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001185185-26-002765 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001185185-26-002764 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-05 | FORM 8-K | 0001185185-26-002410 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001185185-26-001885 | View SEC Doc Filr Page |
| 8-K | 2026-04-20 | 2026-04-14 | FORM 8-K | 0001185185-26-001437 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2026-04-01 | 4 Filing | 0001185185-26-001286 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2026-04-01 | 4 Filing | 0001185185-26-001285 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2026-04-01 | 4 Filing | 0001185185-26-001284 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2026-04-01 | 4 Filing | 0001185185-26-001283 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-30 | FORM 8-K | 0001185185-26-001146 | View SEC Doc Filr Page |
| 10-KT | 2026-03-18 | 2025-12-31 | FORM 10-KT | 0001185185-26-000941 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-06 | FORM 8-K | 0001185185-26-000846 | View SEC Doc Filr Page |
| 4 | 2026-02-04 | 2026-02-03 | 4 Filing | 0001185185-26-000411 | View SEC Doc Filr Page |
| 4 | 2026-01-20 | 2026-01-19 | 4 Filing | 0001185185-26-000218 | View SEC Doc Filr Page |
| 8-K | 2026-01-06 | 2026-01-05 | FORM 8-K | 0001185185-26-000032 | View SEC Doc Filr Page |
| 424B5 | 2026-01-06 | — | FORM 424B5 | 0001185185-26-000030 | View SEC Doc Filr Page |
| 8-K | 2026-01-02 | 2025-12-30 | FORM 8-K | 0001185185-26-000010 | View SEC Doc Filr Page |
| 8-K | 2025-12-15 | 2025-12-12 | FORM 8-K | 0001185185-25-002055 | View SEC Doc Filr Page |
| EFFECT | 2025-12-05 | — | EFFECT Filing | 9999999995-25-003555 | View SEC Doc Filr Page |
| CORRESP | 2025-12-04 | — | CORRESP Filing | 0001185185-25-001921 | View SEC Doc Filr Page |